EP
DXCM icon

Eudaimonia Partners’s DexCom DXCM Stock Holding History

Eudaimonia Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-164
Closed -$15K – 612
2021
Q1 		$15K Sell
164
-88
-35% -$8.26K ﹤0.01% 1046
2020
Q4 		$23K Sell
252
-36
-13% -$3.21K 0.01% 821
2020
Q3 		$30K Hold
288
– – 0.01% 685
2020
Q2 		$29K Buy
+288
New +$25.8K 0.01% 628

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Eudaimonia Partners's DXCM Position: Q2 2021 in Review

Eudaimonia Partners sold out of DexCom (DXCM) in Q2 2021, closing a stake of 164 shares — an estimated $15K sold.

Eudaimonia Partners first reported a position in DXCM in Q2 2020 and held it in 4 quarters. The position peaked at $30K in Q3 2020. 726 funds tracked by Wall St. Rank hold DXCM as of Q2 2021.

  • Eudaimonia Partners reported no remaining DexCom position as of Q2 2021 after selling out during the quarter.
  • Eudaimonia Partners sold 164 DexCom shares in Q2 2021, an estimated $15K.
  • Eudaimonia Partners first reported a position in DexCom in Q2 2020 and held it in 4 quarters.
  • Eudaimonia Partners's DexCom position peaked at $30K in Q3 2020.
  • 726 funds tracked by Wall St. Rank held DexCom as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.